This information may support a more personalized discussion with your provider about whether tirzepatide's dual mechanism poses higher or lower tolerability risk for your genetic profile
GLP-1 prices could get even worse as supplies struggle to keep up with demand
Nausea, vomiting, diarrhea, and constipation are common with tirzepatide and can increase dehydration riska concern for anyone with kidney disease
We know from bariatric surgery data that significant weight loss and altered nutrition absorption can be associated with lower bone density and osteoporosis, says Marilyn Tan, MD, an associate professor of medicine and endocrinologist at Stanford Health Care in California, who was not involved in the study
Retatrutide UK: The Triple Hormone Weight Loss Injection Explained (GLP-1 + GIP + Glucagon) Retatrutide is one of the most talked about next generation weight loss injections because its designed to target three hormone pathways linked to appetite, blood sugar control and energy use (unlike Wegovy and Mounjaro, which target one or two)